Literature DB >> 16391197

Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.

Zhengming Xiong1, Zhen Cheng, Xianzhong Zhang, Manish Patel, Joseph C Wu, Sanjiv S Gambhir, Xiaoyuan Chen.   

Abstract

UNLABELLED: The aim of this study was to change adenovirus tropism by chemical modification of the fiber knobs with PEGylated RGD peptide for targeting integrin alpha(v)beta(3) that is uniquely or highly expressed in tumor cells and neovasculature of tumors of various origins.
METHODS: The first generation Ad (Ad) vector, which expresses the herpes simplex virus type 1 mutant thymidine kinase (HSV1-sr39tk) gene under the control of cytomegalovirus (CMV) promoter was conjugated with poly(ethylene glycol) (PEG) or RGD-PEG. The transduction efficiency of Ads (Adtk, PEG-Adtk, and RGD-PEG-Adtk) into different types of cells (293T, MCF7, MDA-MB-435, and U87MG) was analyzed and quantified by thymidine kinase (TK) assay using 8-(3)H-penciclovir (8-(3)H-PCV) as substrate. The in vivo infectivity of the Ad vectors after intravenous administration into integrin alpha(v)beta(3)-positive U87MG and MDA-MB-435 tumor-bearing athymic nude mice was measured by both noninvasive microPET using 9-[4-(18)F-fluoro-3-(hydroxymethyl)butyl]guanine ((18)F-FHBG) as a reporter probe and ex vivo TK assay of the tumor and tissue homogenates.
RESULTS: PEGylation completely abrogated coxsackievirus and adenovirus receptor (CAR)-knob interaction and the infectivity of PEG-Adtk is significantly lower than that of unmodified Adtk in CAR-positive cells. RGD-PEG-modified virus (RGD-PEG-Adtk) had significantly higher infectivity than PEG-Adtk and the extent of increase is related to both CAR and integrin alpha(v)beta(3) expression levels. (18)F-FHBG had minimal nonspecific uptake in the liver and tumors that are void of sr39tk. Mice preinjected intravenously with unmodified Adtk resulted in high hepatic uptake and moderate tumor accumulation of the tracer. In contrast, RGD-PEG-Adtk administration resulted in significantly lower liver uptake without compromising the tumor accumulation of (18)F-FHBG. Expression of TK in the liver and tumor homogenates corroborated with the magnitude of (18)F-FHBG uptake quantified by noninvasive microPET. Analysis of liver and tumor tissue integrin level confirmed that RGD-integrin interaction is responsible for the enhanced tumor infectivity of RGD-PEG-Adtk.
CONCLUSION: The results of this study suggest that RGD-PEG conjugation is an effective way to modify Ad vector tropism for improved systemic gene delivery. Noninvasive PET and (18)F-FHBG are able to monitor in vivo transfectivity of both Adtk and RGD-PEG-Adtk vectors in the liver and tumors after intravenous injection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391197      PMCID: PMC4154793     

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  38 in total

1.  Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector.

Authors:  P Reynolds; I Dmitriev; D Curiel
Journal:  Gene Ther       Date:  1999-07       Impact factor: 5.250

Review 2.  Gene therapy progress and prospects: noninvasive imaging of gene therapy in living subjects.

Authors:  J J Min; S S Gambhir
Journal:  Gene Ther       Date:  2004-01       Impact factor: 5.250

3.  microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.

Authors:  Yun Wu; Xianzhong Zhang; Zhengming Xiong; Zhen Cheng; Darrell R Fisher; Shuang Liu; Sanjiv S Gambhir; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2005-10       Impact factor: 10.057

4.  Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection.

Authors:  J Zabner; P Freimuth; A Puga; A Fabrega; M J Welsh
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

5.  Sodium dodecyl sulfate-stable complexes of echistatin and RGD-dependent integrins: a novel approach to study integrins.

Authors:  G Thibault
Journal:  Mol Pharmacol       Date:  2000-11       Impact factor: 4.436

6.  Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression.

Authors:  Juri Gelovani Tjuvajev; Mikhail Doubrovin; Timothy Akhurst; Shangde Cai; Julius Balatoni; Mian M Alauddin; Ronald Finn; William Bornmann; Howard Thaler; Peter S Conti; Ronald G Blasberg
Journal:  J Nucl Med       Date:  2002-08       Impact factor: 10.057

Review 7.  Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies.

Authors:  Roland Haubner; Hans-Jürgen Wester
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

Review 8.  Multimodality imaging of tumor integrin alphavbeta3 expression.

Authors:  Xiaoyuan Chen
Journal:  Mini Rev Med Chem       Date:  2006-02       Impact factor: 3.862

9.  An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.

Authors:  I Dmitriev; V Krasnykh; C R Miller; M Wang; E Kashentseva; G Mikheeva; N Belousova; D T Curiel
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Dual targeting of gene delivery by genetic modification of adenovirus serotype 5 fibers and cell-selective transcriptional control.

Authors:  L M Work; N Ritchie; S A Nicklin; P N Reynolds; A H Baker
Journal:  Gene Ther       Date:  2004-08       Impact factor: 5.250

View more
  21 in total

Review 1.  Specific biomarkers of receptors, pathways of inhibition and targeted therapies: pre-clinical developments.

Authors:  Y Waerzeggers; P Monfared; T Viel; A Faust; K Kopka; M Schäfers; B Tavitian; A Winkeler; A Jacobs
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  Titration of variant HSV1-tk gene expression to determine the sensitivity of 18F-FHBG PET imaging in a prostate tumor.

Authors:  Mai Johnson; Breanne D W Karanikolas; Saul J Priceman; Russell Powell; Margaret E Black; Hsiao-Ming Wu; Johannes Czernin; Sung-Cheng Huang; Lily Wu
Journal:  J Nucl Med       Date:  2009-04-16       Impact factor: 10.057

3.  Impact of the arterial input function on microvascularization parameter measurements using dynamic contrast-enhanced ultrasonography.

Authors:  Marianne Gauthier; Stéphanie Pitre-Champagnat; Farid Tabarout; Ingrid Leguerney; Mélanie Polrot; Nathalie Lassau
Journal:  World J Radiol       Date:  2012-07-28

4.  Design of a functional cyclic HSV1-TK reporter and its application to PET imaging of apoptosis.

Authors:  Zhe Wang; Fu Wang; Naoki Hida; Dale O Kiesewetter; Jie Tian; Gang Niu; Xiaoyuan Chen
Journal:  Nat Protoc       Date:  2015-04-30       Impact factor: 13.491

Review 5.  Directing systemic oncolytic viral delivery to tumors via carrier cells.

Authors:  Hiroshi Nakashima; Balveen Kaur; E A Chiocca
Journal:  Cytokine Growth Factor Rev       Date:  2010-03-11       Impact factor: 7.638

6.  Macrocyclic chelator assembled RGD multimers for tumor targeting.

Authors:  Xiaofen Zhang; Hongguang Liu; Zheng Miao; Richard Kimura; Feiyue Fan; Zhen Cheng
Journal:  Bioorg Med Chem Lett       Date:  2011-04-05       Impact factor: 2.823

7.  Targeted radionuclide therapy with RAFT-RGD radiolabelled with (90)Y or (177)Lu in a mouse model of αvβ3-expressing tumours.

Authors:  A Bozon-Petitprin; S Bacot; A S Gauchez; M Ahmadi; J C Bourre; D Marti-Batlle; P Perret; A Broisat; L M Riou; M Claron; D Boturyn; D Fagret; Catherine Ghezzi; J P Vuillez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-28       Impact factor: 9.236

8.  In vivo bioluminescence tumor imaging of RGD peptide-modified adenoviral vector encoding firefly luciferase reporter gene.

Authors:  Gang Niu; Zhengming Xiong; Zhen Cheng; Weibo Cai; Sanjiv S Gambhir; Lei Xing; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2007 May-Jun       Impact factor: 3.488

9.  Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody.

Authors:  Weibo Cai; Kai Chen; Lina He; Qizhen Cao; Albert Koong; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-30       Impact factor: 10.057

10.  Retargeting adenoviral vectors to improve gene transfer into tumors.

Authors:  R T Hogg; P Thorpe; R D Gerard
Journal:  Cancer Gene Ther       Date:  2010-12-24       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.